The training of Pharmacopoeia Committee is worth listening to. Because the training of Pharmacopoeia Committee is carried out around China Pharmacopoeia 2020 (Part III), the standards and testing technologies of antibody drugs, new vaccines and new therapeutic products are interpreted in a targeted manner, and the requirements and key technologies of quality control of recombinant therapeutic biological products are deeply analyzed, aiming at solving the technical difficulties in registration, production and research and development, helping relevant practitioners to improve their overall technical level from theoretical basis to practical ability, and then ensuring China Pharmacopoeia. So the training of Pharmacopoeia Committee is worth listening to.